March 24, 2016
Forbes
By Luke Timmerman
A couple weeks ago, I imagined a “dream team” of people who could break the mold and come up with a more fair, sustainable way for pricing drugs. The goal: Improve access to medicines, improve patient outcomes, and maintain profit incentives for companies to keep developing innovative new ones.
